These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9680126)
1. Vaccinia virus protein B18R inhibits the activity and cellular binding of the novel type interferon-delta. Vancová I; La Bonnardiere C; Kontsek P J Gen Virol; 1998 Jul; 79 ( Pt 7)():1647-9. PubMed ID: 9680126 [TBL] [Abstract][Full Text] [Related]
2. Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2. Liptáková H; Kontseková E; Alcamí A; Smith GL; Kontsek P Virology; 1997 May; 232(1):86-90. PubMed ID: 9185591 [TBL] [Abstract][Full Text] [Related]
3. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. Alcamí A; Symons JA; Smith GL J Virol; 2000 Dec; 74(23):11230-9. PubMed ID: 11070021 [TBL] [Abstract][Full Text] [Related]
4. Cloning, Prokaryotic Soluble Expression, and Analysis of Antiviral Activity of Two Novel Feline IFN-ω Proteins. Wang X; Li F; Han M; Jia S; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu YG Viruses; 2020 Mar; 12(3):. PubMed ID: 32204464 [TBL] [Abstract][Full Text] [Related]
5. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus. Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040 [TBL] [Abstract][Full Text] [Related]
6. Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R. Harris BD; Schreiter J; Chevrier M; Jordan JL; Walter MR J Biol Chem; 2018 Oct; 293(41):16057-16068. PubMed ID: 30171073 [TBL] [Abstract][Full Text] [Related]
7. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. Colamonici OR; Domanski P; Sweitzer SM; Larner A; Buller RM J Biol Chem; 1995 Jul; 270(27):15974-8. PubMed ID: 7608155 [TBL] [Abstract][Full Text] [Related]
8. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities. Subramaniam PS; Khan SA; Pontzer CH; Johnson HM Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883 [TBL] [Abstract][Full Text] [Related]
9. Differential expression and activity of the porcine type I interferon family. Sang Y; Rowland RR; Hesse RA; Blecha F Physiol Genomics; 2010 Jul; 42(2):248-58. PubMed ID: 20406849 [TBL] [Abstract][Full Text] [Related]
10. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2. Piehler J; Schreiber G J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041 [TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Symons JA; Alcamí A; Smith GL Cell; 1995 May; 81(4):551-60. PubMed ID: 7758109 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins. Bandi P; Pagliaccetti NE; Robek MD J Interferon Cytokine Res; 2010 Mar; 30(3):123-34. PubMed ID: 20038204 [TBL] [Abstract][Full Text] [Related]
13. Atypical spI interferon binds on porcine cells to a major component of type I interferon receptor. Niu PD; Lefevre F; La Bonnardiere C J Interferon Cytokine Res; 1995 Sep; 15(9):769-75. PubMed ID: 8536104 [TBL] [Abstract][Full Text] [Related]
14. Interferon-delta: the first member of a novel type I interferon family. Lefèvre F; Guillomot M; D'Andréa S; Battegay S; La Bonnardière C Biochimie; 1998; 80(8-9):779-88. PubMed ID: 9865499 [TBL] [Abstract][Full Text] [Related]
15. How Does Vaccinia Virus Interfere With Interferon? Smith GL; Talbot-Cooper C; Lu Y Adv Virus Res; 2018; 100():355-378. PubMed ID: 29551142 [TBL] [Abstract][Full Text] [Related]
16. Bovine type I interferon receptor protein BoIFNAR-1 has high-affinity and broad specificity for human type I interferons. Langer JA; Yang J; Carmillo P; Ling LE FEBS Lett; 1998 Jan; 421(2):131-5. PubMed ID: 9468293 [TBL] [Abstract][Full Text] [Related]
17. Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector. Kim YG; Baltabekova AZ; Zhiyenbay EE; Aksambayeva AS; Shagyrova ZS; Khannanov R; Ramanculov EM; Shustov AV PLoS One; 2017; 12(12):e0189308. PubMed ID: 29216299 [TBL] [Abstract][Full Text] [Related]
18. Fish virus-induced interferon exerts antiviral function through Stat1 pathway. Yu FF; Zhang YB; Liu TK; Liu Y; Sun F; Jiang J; Gui JF Mol Immunol; 2010 Aug; 47(14):2330-41. PubMed ID: 20627394 [TBL] [Abstract][Full Text] [Related]
19. Preparation of CHO cell-derived rhIFN-ω-Fc with improved pharmacokinetics. Li J; Li B; Zhang J; Hou L; Yu C; Fu L; Song X; Yu T; Zhang J; Ren J; Xu C; Chen W Antiviral Res; 2011 Mar; 89(3):199-203. PubMed ID: 21277904 [TBL] [Abstract][Full Text] [Related]
20. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells. Arsenio J; Deschambault Y; Cao J Virology; 2008 Jul; 377(1):124-32. PubMed ID: 18502465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]